A distinguished figure in the field of cardiovascular research and cardiology, Professor John Greenwood is the Director and Chief Executive of the Baker Heart and Diabetes Institute
Professor John Greenwood is a distinguished figure in the field of cardiovascular research and cardiology. As a consultant cardiologist for almost 20 years at Leeds Teaching Hospitals NHS Trust in the United Kingdom, he specialised in coronary intervention and cardiovascular magnetic resonance (CMR) imaging.
His primary research focus has been improving the diagnosis and treatment of stable and unstable coronary artery disease. In terms of diagnostics, this particularly involved the use of CMR in terms of its development and validation through large-scale clinical trials (CE-MARC and CE-MARC2). In terms of therapeutics, he has collaborated on numerous multi-centre drug and device trials designed to improve outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (STEMI) or stable complex coronary artery disease.
He is President of the British Cardiovascular Society (2021–2024) and a member of the Council of The Royal College of Physicians, London. He was elected to the Board of the British Society of Cardiovascular Magnetic Resonance (BSCMR) in 2008 and was BSCMR President (2018–2020).
He is past Chair of the Society of Cardiovascular Magnetic Resonance (SCMR) clinical trials committee (2015–2017) and was a member of the SCMR scientific programme committee (2016-2019). He was the SCMR representative on the 2021 Guideline for the Evaluation and Diagnosis of Chest Pain. He is also a winner of the SCMR Gold Medal in 2023 and was Associate Editor of JCMR (2017–2023). He is a member of the European Society of Cardiology (ESC) Cardio-policy group (2022–2024), ESC Advocacy Committee (2021–current) and a member of the Assembly of International Governors of the ACC.
Professor Greenwood's expertise and leadership have been widely recognised and his commitment to medical research and clinical practice will continue to shape the future of healthcare.